Prostate cancer vaccines: an old yet novel target, the androgen receptor

ISSN： 1476-0584

Source： Expert Review of Vaccines, Vol.12, Iss.3, 2013-03, pp. : 249-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer

By Mazzucchelli Roberta

Cellular Oncology, Vol. 34, Iss. 3, 2011-06 ,pp. : 235-243

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer vaccines

By Michael Agnieszka Relph Kate Annels Nicola Pandha Hardev

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 253-262

Informa Healthcare

Access to resources Recommend Favorite

The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients

By Komiya

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 257-262

Spandidos Publications

Access to resources Recommend Favorite

The ErbB receptor family: a therapeutic target for cancer

By de Bono J.S. Rowinsky E.K.

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 19-26

Elsevier

Access to resources Recommend Favorite

Vaccines for cancer

By Wang R.-F.

Trends in Molecular Medicine, Vol. 7, Iss. 7, 2001-07 ,pp. : 326-326

Elsevier

Access to resources Recommend Favorite